BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9662195)

  • 1. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients.
    Vignoli M; Stecca B; Furlini G; Re MC; Mantovani V; Zauli G; Visani G; Colangeli V; La Placa M
    AIDS; 1998 Jun; 12(9):999-1005. PubMed ID: 9662195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific ligation of the HIV-1 viral envelope protein gp120 on human CD34+ bone marrow-derived progenitors.
    Arock M; Dedenon A; Le Goff L; Michel A; Missenard G; Debré P; Guillosson JJ
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):319-23. PubMed ID: 7522715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction.
    Gibellini D; Vitone F; Buzzi M; Schiavone P; De Crignis E; Cicola R; Conte R; Ponti C; Re MC
    J Cell Physiol; 2007 Feb; 210(2):315-24. PubMed ID: 17111363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication.
    Costantini A; Giuliodoro S; Mancini S; Butini L; Regnery CM; Silvestri G; Greco F; Leoni P; Montroni M
    AIDS; 2006 Aug; 20(13):1713-20. PubMed ID: 16931935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.
    Chiu CP; Dragowska W; Kim NW; Vaziri H; Yui J; Thomas TE; Harley CB; Lansdorp PM
    Stem Cells; 1996 Mar; 14(2):239-48. PubMed ID: 8991544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in human hematopoietic progenitor cells.
    Hohaus S; Voso MT; Orta-La Barbera E; Cavallo S; Bellacosa A; Rutella S; Rumi C; Genuardi M; Neri G; Leone G
    Haematologica; 1997; 82(3):262-8. PubMed ID: 9234570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
    Vogel W; Kopp HG; Kanz L; Einsele H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.
    Stanley SK; Kessler SW; Justement JS; Schnittman SM; Greenhouse JJ; Brown CC; Musongela L; Musey K; Kapita B; Fauci AS
    J Immunol; 1992 Jul; 149(2):689-97. PubMed ID: 1378076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human telomerase reverse transcriptase in bone marrow CD34+ cells from patients with beta-thalassemia major.
    Li X; Qu Y; Mao M; Yu F; Li Q; Hua Y; Mu D
    Transfusion; 2008 Aug; 48(8):1627-33. PubMed ID: 18466174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals.
    Banda NK; Simon GR; Sipple JD; Terrell KL; Archer P; Shpall EJ; Akkina RK; Myers AM; Harrison GS
    Biol Blood Marrow Transplant; 1999; 5(3):162-72. PubMed ID: 10392962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1.
    Zauli G; Vitale M; Gibellini D; Capitani S
    J Exp Med; 1996 Jan; 183(1):99-108. PubMed ID: 8551249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
    Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.
    Oelschlaegel U; Bornhaeuser M; Thiede C; Ehninger G; Hoelig K
    Cytotherapy; 2003; 5(5):414-9. PubMed ID: 14578103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of down regulating of p27 on the activity of hematopoietic progenitor cells derived from umbilical cord blood and bone marrow ex vivo].
    Li L; Li XX; Cheng T
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):90-3. PubMed ID: 15921625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
    Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
    Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.